This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
May 04, 2021
Pulmonx Reports First Quarter 2021 Financial Results
May 04, 2021
Pulmonx Corporation Expands Leadership Team
May 04, 2021
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF
May 03, 2021
Q1 2021 General Market Overview
April 29, 2021
Adcendo raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers
April 29, 2021
BONESUPPORT HOLDING AB (publ) – Interim Report Q1 2021 Invitation to conference call and webcast
April 29, 2021
Orexo Q1 2021 Interim Report
April 28, 2021
Precirix partners with Evergreen to expand North American clinical trial supply
April 28, 2021
Nordic Nanovector ASA: Annual General Meeting held
April 27, 2021
Targovax ASA: Invitation to presentation of Targovax’s first quarter 2021 results, Thursday 6 May